Urogen Pharma Ltd (URGN)

Net Income Growth

71.26%

Quarterly · Period ending:

URGN logo

URGN Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported71.26%
URGN Quarterly Net Income YoY % (-479.56% → 71.26%)
High-resolution chart · PNG

URGN net income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Net Income Growth — Quarterly
Period endingNet Income Growth
71.2635%
46.2309%
29.7185%
-40.8651%
-49.5075%
-35.7957%
-44.1882%
-8.1996%
-38.3949%
-6.8613%
9.8826%
15.2994%
9.5725%
-6.4138%
-1.4656%
14.498%
-1.7886%
-9.4737%
6.7942%
-4.8411%
16.3546%
31.3762%
21.674%
-29.4985%
-39.4715%
-76.2404%
-64.3252%
-8.3719%
-24.6921%
-60.2451%
-135.5915%
-6,790.2685%
-190.7888%
-291.6301%
-181.8389%
96.2689%
-86.8857%
17.9%
265.5585%
-94.0326%
-479.5632%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.